Multilevel Factors Associated with HPV Vaccine Initiation and Completion among Mexican American Young Adult Women from Federally Qualified Health Centers in Orange County, CA

加州橙县联邦认证医疗中心墨西哥裔美国年轻女性HPV疫苗接种启动和完成情况的多层次影响因素

阅读:1

Abstract

Latina women experience cancer disparities exacerbated by multilevel factors. An understanding of how multilevel factors influence Latinas' use of prevention services, can inform culturally tailored interventions. Using cross-sectional surveys guided by the NIMHD Health Disparities Research Framework, we sought to identify individual (HPV vaccine hesitancy, HPV knowledge, HPV vaccine conspiracy beliefs), interpersonal (strength of provider communication, mother-daughter communication), and community (negative HPV vaccine messages, number of times offered the HPV vaccine, clinic wait times) factors associated with HPV vaccine initiation and completion among Mexican American young adult women. At the individual level, HPV vaccine hesitancy and HPV vaccine conspiracy beliefs were associated with HPV vaccine initiation and completion. HPV vaccine knowledge was not associated with initiation or completion. At the individual level, strength of provider communication and HPV mother-daughter communication was associated with HPV vaccine initiation. Only HPV mother-daughter communication was associated with HPV vaccine completion. At the community level, longer clinic wait times and number of times the HPV vaccine has been offered was associated with HPV vaccine initiation. Exposure to negative HPV vaccine messages was not associated with HPV vaccine initiation but was associated with HPV vaccine completion. Longer clinic wait times and number of times the HPV vaccine was offered was not associated with completion. Findings suggest multilevel factors that influence HPV vaccine initiation can differ from factors that influence completion, an important factor to consider when designing interventions tailored to meet the needs of this population or when implementing evidence-based strategies for HPV vaccination.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。